Viking Therapeutics Corp (VKTX): PEG Multiple

Symbol and logo of brand vikingtherapeutics.com (VKTX)

Viking Therapeutics (VKTX) is currently at the peak of investor confidence due to its successes in combating obesity. The ratio of valuation to business expansion rates on the GURU.Markets chart shows that the indicator value is 0.00. Viking Therapeutics relies on external drug manufacturers using an asset-light model, while it retains a staff of top scientists through generous options and grants.

Viking Therapeutics Corp (VKTX): Price/Earnings to Growth Ratio from 07/04/2022 to 11/16/2026

Viking Therapeutics, Inc. (VKTX) - metric breakdowns and financial figures

Summary company analytics:Viking Pharma
Manufactured product of vikingtherapeutics.com

The PEG ratio compares the P/E multiple with earnings growth rates, allowing for a determination of whether a stock price is fair relative to business dynamics. By analyzing the average PEG value, an investor assesses the capitalization efficiency of Viking Therapeutics (VKTX), whose market value depends directly on the success of clinical trials for anti-obesity drugs in the competition against global pharma behemoths.

Competing companies

Growth-Adjusted Market Cap to Net Income Biogen Idec|Neurocrine Corp - Price/Earnings to Growth Multiple|regencellbioscience.com (RGC) - Price to Earnings Adjusted for Growth Rate|AXSM - Price/Earnings to Growth Ratio|ACAD (ACADIA Pharmaceuticals Inc.) - Growth-Adjusted P/E Ratio|Xenon Pharmaceuticals (XENE) - Price/Earnings to Growth Ratio|Supernus Corp - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Multiple CPRX|Denali Therapeutics Inc. (DNLI) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple HRMY (Harmony Corp)|BHVN - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Amylyx Pharmaceuticals, Inc. AMLX|Growth-Adjusted Payback Ratio TRVI|PRAX - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income Anavex Life Sciences AVXL|CBLL: PEG Multiple|Price/Earnings to Growth Multiple Prothena Corporation PLC|ALEC (alector.com) - PEG Multiple|Price/Earnings to Growth Multiple Annexon, Inc. (ANNX)|Price/Earnings to Growth Ratio Omeros Corporation (OMER)|Neurogene Inc. - Growth-Adjusted P/E Ratio|acimmune.com - Price/Earnings to Growth Multiple|PEG Multiple Voyager Therapeutics Inc VYGR|NMRA - Price/Earnings to Growth Ratio|Price to Net Income Growth Ratio Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio ACOG|Price/Earnings to Growth Ratio Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Market Cap to Earnings and Growth Ratio|Price/Earnings to Growth Multiple SAVA (Cassava)|Growth-Adjusted Market Cap to Net Income Assertio Therapeutics|Coya Therapeutics, Inc. - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - PEG Multiple|Acumen Pharmaceuticals, Inc. (ABOS) - Price/Earnings to Growth Multiple|CRVO (CervoMed, Inc.) - Price/Earnings to Growth Multiple|Price/Earnings to Growth Multiple Alterity Therapeutics Ltd|Price/Earnings to Growth Ratio Clene Inc.|PepGen Inc. - Market Cap to Earnings and Growth Ratio|Price/Earnings to Growth Multiple JUNS (Jupiter Neurosciences Inc)|Price/Earnings to Growth Ratio RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Price/Earnings to Growth Multiple|Growth-Adjusted Market Cap to Net Income Grace Tx (GRCE)|fireflyneuro.com - PEG Multiple|Klotho Neurosciences (KLTO) - Price/Earnings to Growth Multiple|NeuroSense Therapeutics, Ltd. (NRSN) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - PEG Multiple|NRXS: Growth-Adjusted Payback Ratio|PEG Multiple HSDT|PEG Multiple Passage Bio Inc. (PASG)|Price/Earnings to Growth Ratio bionomics.com.au NEUP|PEG Multiple Minerva Neurosciences Inc NERV|ATHA: Price/Earnings to Growth Multiple|ADXN (Addex Therapeutics, Ltd.) - Growth-Adjusted P/E Ratio|Alzamend Neuro Inc. (ALZN) - Price/Earnings to Growth Ratio|Cyclerion - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio protagenic.com|Pasithea Therapeutics - Market Cap to Earnings and Growth Ratio|Price/Earnings to Growth Multiple CRGT (Cortigent, Inc.)|Avenue Therapeutics - Growth-Adjusted P/E Ratio|Price/Earnings to Growth Ratio Brainstorm Cell BCLI|PEG Multiple caratherapeutics.com CARA|Chromocell Therapeutics Corp. - PEG Multiple|eliemtx.com - Company Value to Earnings Growth Ratio|Intra-Cellular Therapies (ITCI) - Price/Earnings to Growth Ratio|LBPH (Longboard) - Price/Earnings to Growth Ratio|MRNS (marinuspharma.com) - PEG Multiple|Price to Earnings Adjusted for Growth Rate NKGen Biotech NKGN|Price/Earnings to Growth Ratio NeuroBo Pharma (NRBO)|Company Value to Earnings Growth Ratio SAGE|Synaptogenix, Inc. - Price/Earnings to Growth Multiple|TRVN: Growth-Adjusted P/E Ratio|VIGL - Price/Earnings to Growth Ratio|Growth-Adjusted Payback Ratio WENA (Anew Medical, Inc.)|CERE: PEG Multiple